Activation of receptors δ (PPARδ) by agonist (GW0742) may enhance lipid metabolism in heart both in vivo and in vitro

Hormone and Metabolic Research

Volumn 45, Issue 12, 2013, Pages 880-886

  Kuo, S C ^a,b   Ku, P M ^a   Chen, L J ^c   Niu, H S ^d   Cheng, J T ^a,e  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d TZU CHI COLLEGE OF TECHNOLOGY   (Taiwan)

^e CHANG JUNG CHRISTIAN UNIVERSITY   (Taiwan)

Author keywords

cardiomyocytes; digoxin; fatty acid oxidation; PPAR ; TCA cycle gene

Indexed keywords

3 [(4 ANILINO 2 METHOXYPHENYL)SULFAMOYL] 2 THENOIC ACID METHYL ESTER; [4 [2 (3 FLUORO 4 TRIFLUOROMETHYLPHENYL) 4 METHYL 5 THIAZOLYLMETHYLTHIO] 2 METHYLPHENOXY]ACETIC ACID; ACYL COENZYME A OXIDASE; FATTY ACID; LONG CHAIN ACETYL COENZYME A DEHYDROGENASE; LONG CHAIN ACYL COENZYME A DEHYDROGENASE; MALONYL COENZYME A DECARBOXYLASE; PALMITOYL ACETYL COENZYME A OXIDASE 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PORPHOBILINOGEN DEAMINASE; PYRUVATE DEHYDROGENASE KINASE 4; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 3; VERY LONG CHAIN ACYL COENZYME A DEHYDROGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CITRIC ACID CYCLE; CONTROLLED STUDY; FATTY ACID OXIDATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEART MUSCLE CELL; HEART MUSCLE METABOLISM; IN VITRO STUDY; IN VIVO STUDY; LIPID METABOLISM; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT DURATION; WESTERN BLOTTING;

RATTUS; RATTUS NORVEGICUS;

ANIMALS; ANIMALS, NEWBORN; CITRIC ACID CYCLE; FATTY ACIDS; GENE EXPRESSION REGULATION; LIPID METABOLISM; MALE; MYOCARDIUM; MYOCYTES, CARDIAC; OXIDATION-REDUCTION; PPAR DELTA; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; THIAZOLES;

EID: 84887840722     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0033-1348317     Document Type: Article

References (38)

1. Yang Q., Li Y. Roles of PPARs on regulating myocardial energy and lipid homeostasis. J Mol Med: 2007; 85 697 706 (Pubitemid 47063523)
2. Issemann I., Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature: 1990; 347 645 650
3. Cheng L., Ding G., Qin Q., Huang Y., Lewis W., He N., Evans R. M., Schneider M. D., Brako F. A., Xiao Y., Chen Y. E., Yang Q. Cardiomyocyte- restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy. Nat Med: 2004; 10 1245 1250 (Pubitemid 39540443)
4. Cheng L., Ding G., Qin Q., Xiao Y., Woods D., Chen Y. E., Yang Q. Peroxisome proliferator-activated receptor delta activates fatty acid oxidation in cultured neonatal and adult cardiomyocytes. Biochem Biophys Res Commun: 2004; 313 277 286 (Pubitemid 37543582)
5. Barish G. D., Narkar V. A., Evans R. M. PPAR delta: a dagger in the heart of the metabolic syndrome. J Clin Invest: 2006; 116 590 597 (Pubitemid 43326863)
6. Planavila A., Rodriguez-Calvo R., Jove M., Michalik L., Wahli W., Laguna J. C., Vazquez-Carrera M. Peroxisome proliferator-activated receptor beta/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes. Cardiovasc Res: 2005; 65 832 841 (Pubitemid 40249728)
7. Pesant M., Sueur S., Dutartre P., Tallandier M., Grimaldi P. A., Rochette L., Connat J. L. Peroxisome proliferator-activated receptor delta (PPARdelta) activation protects H9c2 cardiomyoblasts from oxidative stress-induced apoptosis. Cardiovasc Res: 2006; 69 440 449 (Pubitemid 43098800)
8. Finck B. N., Kelly D. P. Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) regulatory cascade in cardiac physiology and disease. Circulation: 2007; 115 2540 2548 (Pubitemid 46763228)
9. Rimbaud S., Garnier A., Ventura-Clapier R. Mitochondrial biogenesis in cardiac pathophysiology. Pharmacol Rep: 2009; 61 131 138
10. Ventura-Clapier R., Garnier A., Veksler V. Transcriptional control of mitochondrial biogenesis: the central role of PGC-1alpha. Cardiovasc Res: 2008; 79 208 217 (Pubitemid 351951611)
11. Sack M. N., Kelly D. P. The energy substrate switch during development of heart failure: gene regulatory mechanisms (Review). Int J Mol Med: 1998; 1 17 24
12. Bugger H., Abel E. D. Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome. Clin Sci (Lond): 2008; 114 195 210 (Pubitemid 351293995)
13. Yu B. C., Chang C. K., Ou H. Y., Cheng K. C., Cheng J. T. Decrease of peroxisome proliferator-activated receptor delta expression in cardiomyopathy of streptozotocin-induced diabetic rats. Cardiovasc Res: 2008; 80 78 87
14. Fan S. C., Yu B. C., Chen Z. C., Chen L. J., Chung H. H., Cheng J. T. The decreased expression of peroxisome proliferator-activated receptors delta (PPARdelta) is reversed by digoxin in the heart of diabetic rats. Horm Metab Res: 2010; 42 637 642
15. Sznaidman M. L., Haffner C. D., Maloney P. R., Fivush A., Chao E., Goreham D., Sierra M. L., LeGrumelec C., Xu H. E., Montana V. G., Lambert M. H., Willson T. M., Oliver W. R. Jr., Sternbach D. D. Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta (PPARdelta) - synthesis and biological activity. Bioorg Med Chem Lett: 2003; 13 1517 1521 (Pubitemid 36428550)
16. Bility M. T., Devlin-Durante M. K., Blazanin N., Glick A. B., Ward J. M., Kang B. H., Kennett M. J., Gonzalez F. J., Peters J. M. Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPAR beta/delta) inhibits chemically induced skin tumorigenesis. Carcinogenesis: 2008; 29 2406 2414
17. Gaudel C., Schwartz C., Giordano C., Abumrad N. A., Grimaldi P. A. Pharmacological activation of PPARbeta promotes rapid and calcineurin-dependent fiber remodeling and angiogenesis in mouse skeletal muscle. Am J Physiol Endocrinol Metab: 2008; 295 E297 E304
18. Wagner N., Jehl-Pietri C., Lopez P., Murdaca J., Giordano C., Schwartz C., Gounon P., Hatem S. N., Grimaldi P., Wagner K. D. Peroxisome proliferator-activated receptor beta stimulation induces rapid cardiac growth and angiogenesis via direct activation of calcineurin. Cardiovasc Res: 2009; 83 61 71
19. Chen Z. C., Lee K. S., Chen L. J., Wang L. U., Niu H. S., Cheng J. T. Cardiac peroxisome proliferator-activated receptor d (PPARd) as a new target for increased contractility without altering heart rate. PloS one: 2013; in press
20. Zarzuelo M. J., Jimenez R., Galindo P., Sanchez M., Nieto A., Romero M., Quintela A. M., Lopez-Sepulveda R., Gomez-Guzman M., Bailon E., Rodriguez-Gomez I., Zarzuelo A., Galvez J., Tamargo J., Perez-Vizcaino F., Duarte J. Antihypertensive effects of peroxisome proliferator-activated receptor-beta activation in spontaneously hypertensive rats. Hypertension: 2011; 58 733 743
21. Paterniti I., Esposito E., Mazzon E., Galuppo M., Di Paola R., Bramanti P., Kapoor A., Thiemermann C., Cuzzocrea S. Evidence for the role of peroxisome proliferator-activated receptor-beta/delta in the development of spinal cord injury. J Pharmacol Exp Therapeut: 2010; 333 465 477
22. Kannel W. B., Hjortland M., Castelli W. P. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol: 1974; 34 29 34
23. Cohen G., Riahi Y., Shamni O., Guichardant M., Chatgilialoglu C., Ferreri C., Kaiser N., Sasson S. Role of lipid peroxidation and PPAR-delta in amplifying glucose-stimulated insulin secretion. Diabetes: 2011; 60 2830 2842
24. Chou M. T., Lo S. H., Cheng K. C., Li Y. X., Chen L. J., Cheng J. T. Activation of beta-adrenoceptors by dobutamine may induce a higher expression of peroxisome proliferator-activated receptors delta (PPARdelta) in neonatal rat cardiomyocytes. Sci World J 2012; 2012: 248320.
25. Chen Z. C., Yu B. C., Chen L. J., Cheng K. C., Lin H. J., Cheng J. T. Characterization of the mechanisms of the increase in PPARdelta expression induced by digoxin in the heart using the H9c2 cell line. Br J Pharmacol: 2011; 163 390 398
26. Chen Z. C., Yu B. C., Chen L. J., Cheng J. T. Increase of Peroxisome Proliferator-activated Receptor delta (PPARdelta) by Digoxin to Improve Lipid Metabolism in the Heart of Diabetic Rats. Horm Metab Res: 2013; 45 364 371
27. Collino M., Benetti E., Miglio G., Castiglia S., Rosa A. C., Aragno M., Thiemermann C., Fantozzi R. Peroxisome proliferator-activated receptor beta/delta agonism protects the kidney against ischemia/reperfusion injury in diabetic rats. Free Radic Biol Med: 2011; 50 345 353
28. Kapoor A., Shintani Y., Collino M., Osuchowski M. F., Busch D., Patel N. S., Sepodes B., Castiglia S., Fantozzi R., Bishop-Bailey D., Mota-Filipe H., Yaqoob M. M., Suzuki K., Bahrami S., Desvergne B., Mitchell J. A., Thiemermann C. Protective role of peroxisome proliferator-activated receptor-beta/delta in septic shock. Am J Respir Crit Care Med: 2010; 182 1506 1515
29. Schiaffino S., Serrano A. Calcineurin signaling and neural control of skeletal muscle fiber type and size. Trends Pharmacol Sci: 2002; 23 569 575 (Pubitemid 35375802)
30. Hokanson J. F., Mercier J. G., Brooks G. A. Cyclosporine A decreases rat skeletal muscle mitochondrial respiration in vitro. Am J Respir Crit Care Med: 1995; 151 1848 1851
31. Zhou L., Cabrera M. E., Okere I. C., Sharma N., Stanley W. C. Regulation of myocardial substrate metabolism during increased energy expenditure: insights from computational studies. Am J Physiol Heart Circ Physiol: 2006; 291 H1036 H1046 (Pubitemid 44343647)
32. Braissant O., Foufelle F., Scotto C., Dauca M., Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology: 1996; 137 354 366 (Pubitemid 26005011)
33. Takahashi S., Tanaka T., Sakai J. New therapeutic target for metabolic syndrome: PPARdelta. Endocr J: 2007; 54 347 357 (Pubitemid 47105421)
34. Wang Y. X., Zhang C. L., Yu R. T., Cho H. K., Nelson M. C., Bayuga-Ocampo C. R., Ham J., Kang H., Evans R. M. Regulation of muscle fiber type and running endurance by PPARdelta. PLoS Biol: 2004; 2 e294
35. Lin J., Wu H., Tarr P. T., Zhang C. Y., Wu Z., Boss O., Michael L. F., Puigserver P., Isotani E., Olson E. N., Lowell B. B., Bassel-Duby R., Spiegelman B. M. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature: 2002; 418 797 801
36. Wang Y. X., Lee C. H., Tiep S., Yu R. T., Ham J., Kang H., Evans R. M. Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell: 2003; 113 159 170 (Pubitemid 36514968)
37. Luquet S., Lopez-Soriano J., Holst D., Fredenrich A., Melki J., Rassoulzadegan M., Grimaldi P. A. Peroxisome proliferator-activated receptor delta controls muscle development and oxidative capability. FASEB J: 2003; 17 2299 2301 (Pubitemid 39561472)
38. Kleiner S., Nguyen-Tran V., Bare O., Huang X., Spiegelman B., Wu Z. PPAR{delta} agonism activates fatty acid oxidation via PGC-1{alpha} but does not increase mitochondrial gene expression and function. J Biol Chem: 2009; 284 18624 18633